Binder P S
Ophthalmology Research Laboratory, Sharp Cabrillo Hospital, San Diego, California.
Cornea. 1989;8(2):106-14.
Five cases of culture-proven Acanthamoeba keratitis underwent cryotherapy to the host cornea as an adjunctive treatment to medical and surgical therapy. Four of the 5 cases had progression of disease while receiving medical therapy considered to be appropriate for Acanthamoeba keratitis. One case underwent cryotherapy to the entire cornea after the disease had recurred in two penetrating keratoplasties; the organisms were eliminated but the patient never recovered useful vision. Two cases underwent cryotherapy to the host cornea at the time of a second penetrating keratoplasty. The organism was eliminated in both cases. Two cases underwent cryotherapy to the host cornea at the time of primary corneal transplantation with elimination of the organism and recovery of excellent acuity. This study does not provide conclusive evidence that cryotherapy eliminated the organism, but suggests that it can be an adjunctive measure to medical and surgical therapy. The risks of the adverse effects of freezing of the cornea must be weighted against the possibility of recurrence after keratoplasty with spread of disease to the sclera or to the development of corneal melting and perforation. Prevention of Acanthamoeba keratitis is by far the best approach to this disease entity.
五例经培养证实的棘阿米巴角膜炎患者接受了对患眼角膜的冷冻疗法,作为药物和手术治疗的辅助治疗。5例患者中有4例在接受被认为适用于棘阿米巴角膜炎的药物治疗时病情仍有进展。1例患者在两次穿透性角膜移植术后疾病复发,对整个角膜进行了冷冻疗法;病原体被清除,但患者最终未恢复有用视力。2例患者在第二次穿透性角膜移植时对患眼角膜进行了冷冻疗法。两例患者的病原体均被清除。2例患者在初次角膜移植时对患眼角膜进行了冷冻疗法,病原体被清除且视力恢复良好。本研究未提供确凿证据表明冷冻疗法能清除病原体,但提示其可作为药物和手术治疗的辅助措施。角膜冷冻的不良反应风险必须与角膜移植术后疾病复发扩散至巩膜或发生角膜溶解穿孔的可能性相权衡。预防棘阿米巴角膜炎是目前应对这种疾病的最佳方法。